Also Known As
MPA
Mycophenolate Mofetil
MMF
Mycophenolate Sodium
[may be referred to by brand names (see MedlinePlus Drug Information) ]
Formal Name
Mycophenolic Acid
This article was last reviewed on
This article waslast modified on December 3, 2017.
At a Glance
Why Get Tested?

To determine the concentration of mycophenolic acid (MPA), an immunosuppressant drug, in the blood in order to monitor levels in transplant recipients and prevent toxicity

When To Get Tested?

As soon as mycophenolate therapy begins and whenever the dose is changed; may be ordered frequently at first, then at regular intervals; whenever excess or deficient levels of MPA are suspected

Sample Required?

A blood sample drawn from a vein in your arm

Test Preparation Needed?

None

You may be able to find your test results on your laboratory's website or patient portal. However, you are currently at Lab Tests Online. You may have been directed here by your lab's website in order to provide you with background information about the test(s) you had performed. You will need to return to your lab's website or portal, or contact your healthcare practitioner in order to obtain your test results.

Lab Tests Online is an award-winning patient education website offering information on laboratory tests. The content on the site, which has been reviewed by laboratory scientists and other medical professionals, provides general explanations of what results might mean for each test listed on the site, such as what a high or low value might suggest to your healthcare practitioner about your health or medical condition.

The reference ranges for your tests can be found on your laboratory report. They are typically found to the right of your results.

If you do not have your lab report, consult your healthcare provider or the laboratory that performed the test(s) to obtain the reference range.

Laboratory test results are not meaningful by themselves. Their meaning comes from comparison to reference ranges. Reference ranges are the values expected for a healthy person. They are sometimes called "normal" values. By comparing your test results with reference values, you and your healthcare provider can see if any of your test results fall outside the range of expected values. Values that are outside expected ranges can provide clues to help identify possible conditions or diseases.

While accuracy of laboratory testing has significantly evolved over the past few decades, some lab-to-lab variability can occur due to differences in testing equipment, chemical reagents, and techniques. This is a reason why so few reference ranges are provided on this site. It is important to know that you must use the range supplied by the laboratory that performed your test to evaluate whether your results are "within normal limits."

For more information, please read the article Reference Ranges and What They Mean.

What is being tested?

Mycophenolic acid (MPA) is the active metabolite of mycophenolate, a drug that is primarily given to people who have had a heart, kidney, or liver transplant to help prevent rejection and secondarily to people with a variety of autoimmune disorders. This test measures the amount of mycophenolic acid in the blood.

Normally, a healthy immune system distinguishes the body's own healthy tissue (self) from threats such as viruses, bacteria, and parasites (non-self). However, the immune system recognizes a transplanted organ as non-self and may attack it. In the case of autoimmune disorders, the immune system mistakenly targets the body's own cells and tissues, causing damage and inflammation.

Mycophenolate belongs to a group of drugs called immunosuppressants that suppress the immune system and helps to prevent organ rejection, tissue inflammation, and damage. Mycophenolate acts by inhibiting formation of an enzyme necessary to produce special immune cells called T-lymphocytes and B-lymphocytes. Inhibiting lymphocyte formation decreases both immune system function and antibody production, reducing the body's immune response to transplanted organs or to its own tissues and cells.

Organ transplant recipients receive mycophenolate in conjunction with other immunosuppressant drugs such as cyclosporine and tacrolimus. Autoimmune disorder patients may be prescribed mycophenolate as a single agent, although they may take other medications. It has been used to treat lupus (especially with symptoms of kidney disease), rheumatoid arthritis, vasculitis, inflammatory bowel disease such as Crohns disease, inflammatory eye diseases including iritis and scleritis, and some other kidney or skin disorders.

Mycophenolate, like most immunosuppressants, must be maintained within a narrow therapeutic range. If the level is too low, organ rejection may occur; if it is too high, then the person may develop toxicity. The mycophenolic acid blood test uses blood samples collected when the drugs are at their lowest, typically just prior to the next dose. Such levels are called trough levels and they are correlated to clinical side effects.

How is the sample collected for testing?

A blood sample is obtained by inserting a needle into a vein in the arm.

Is any test preparation needed to ensure the quality of the sample?

No test preparation is needed.

Accordion Title
Common Questions
  • How is it used?

    The mycophenolic acid (MPA) test is ordered to monitor the amount of the drug in the blood over time in organ transplant recipients who are taking the drug to prevent organ rejection. The test is used to determine whether the drug concentration is within the therapeutic range and is below the toxic level. Treatment with MPA is monitored because the range in which the drug is effective but not toxic is very narrow.

    MPA is an immunosuppressant, meaning it works by dampening the body's immune system. This medication is usually given with cyclosporine and a steroid medication. It was used originally in the management of patients with organ transplants to prevent rejection of transplanted kidney, hearts, and livers. MPA is now also used to treat some autoimmune diseases (see the "What is being tested?" section for more).

    A health practitioner may order an MPA test to monitor drug interaction with other immunosuppressants in combination therapy or to correlate with clinical symptoms and side effects. If someone is taking MPA in addition to cyclosporine or tacrolimus, the health practitioner will order both MPA as well as the other immunosuppressant drug tests.

    Since MPA can lower white blood cell counts and cause anemia, a health practitioner usually orders a complete blood count (CBC) along with MPA to evaluate the blood cells. Other tests, such as a liver panel or renal panel, may also be periodically ordered to evaluate organ function since MPA levels can be affected by changes in kidney and liver function.

  • When is it ordered?

    MPA and complete blood count (CBC) tests are ordered frequently at the start of therapy and then at intervals for as long as the person is taking mycophenolate. The MPA test may be performed whenever there is a change in dosage, a change in other medications that the person is taking, or whenever someone has persistent side effects, toxicity, or organ rejection.

    The most common side effects include:

    • Upset stomach or pain
    • Constipation
    • Diarrhea
    • Nausea and/or vomiting
    • Gas
    • Sleeplessness (insomnia)
    • Tremors
    • Muscle pain
    • Rash
    • Headache

    Some side effects can be serious. If any of the following become severe or persistent, the person's healthcare provider should be notified, who may wish to check the level of drug:

    • Swelling of the hands, arms, feet, ankles or lower legs
    • Difficulty breathing
    • Chest pain
    • Itching
    • Fast heartbeat
    • Dizziness, fainting, lack of energy
    • Pale skin
    • Black or tarry stools, blood in stools
    • Bloody vomit

    People older than 65 may have increased risk for some side effects, particularly infections and gastrointestinal bleeding.

  • What does the test result mean?

    An MPA level that is higher than the therapeutic range may cause toxicity. A level that is below the range may lead to rejection of the transplanted organ. Depending on the results, a health practitioner may adjust the dose that the person is given.

    Monitoring blood levels can help establish the range in which mycophenolic acid is therapeutic for a particular individual (i.e., individualize therapy). The level at which the person has minimal side effects but is not rejecting the organ is the target range for that person. If other immunosuppressants and/or drugs are added or illnesses occur, the healthcare provider can adjust the dose of mycophenolic acid, if necessary, until the blood level falls within the individualized therapeutic range for this person.

  • Is there anything else I should know?

    Mycophenolic acid levels can be affected by other medications. Drugs that reduce MPA concentrations include antacids containing magnesium or aluminum hydroxide and cholestyramine. Drugs that can increase MPA include ganciclovir, probenecid, and acyclovir. Herbal supplements such as Echinacea, Cats Claw, and St. John's wort should be avoided while taking mycophenolate.

    A partial list of medications that may also interfere with mycophenolate includes:

    • Azathioprine (Imuran)
    • Trimethoprim/sulfamethoxazole (Bactrim)
    • Theophylline (Theo-Dur)
    • Phenytoin (Dilantin)
    • Aspirin and other salicylates

    Oral contraceptives can interfere with MPA, while MPA can decrease the effectiveness of oral contraceptives and has been linked with first trimester miscarriages and congenital birth defects. Women should not become pregnant while taking mycophenolate and should not breastfeed. Two forms of birth control are recommended as is a pregnancy test prior to the start of the medication. Women who become pregnant should talk to their health practitioner about the associated risks.

    Those who are taking mycophenolate should talk to their healthcare provider before getting any vaccines. MPA could increase risk of infection.

    People may have side effects and experience complications such as infections and slow healing even when taking mycophenolate properly. Like other immunosuppressant agents, MPA is associated with an increased risk of infection and the development of both lymphoma and skin cancer. People who take MPA should avoid exposure to sunlight and wear protective clothing and sunscreen (SPF 30 or higher) when they are outdoors.

  • How long will I need to be on mycophenolate?

    Typically, mycophenolate is given long term, but it depends on your condition and how you respond to the drug. Mycophenolate is one choice in an array of medications that may be used to help treat your condition. If you are a transplant patient, you must take an immunosuppressant (or combination of drugs) throughout your life. If you are a patient with an autoimmune disorder, then you will be prescribed medications to help limit damage to your body and to alleviate symptoms. Talk to your healthcare provider about the best choices for your condition. These choices may change over time.

  • Where are mycophenolic acid tests performed?

    Mycophenolic acid tests may be performed in a local hospital laboratory but will frequently be sent to a reference laboratory. Because different laboratories use different methods and will have slightly different reference ranges, your health practitioner will usually send your tests consistently to one laboratory for testing.

  • Should I tell my other healthcare providers that I am taking mycophenolate?

    Yes. This is important information for them, partially because of drug interactions and partially because of the immunosuppressant action of mycophenolic acid. It can affect your ability to heal, to get vaccinations, and may increase the risk of developing certain cancers, including skin cancers and lymphoma.

View Sources

Sources Used in Current Review

Mycophenolate Mofetil (CellCept) and Mycophenolate Sodium (Myfortic). American College of Rheumatology. Available online at http://www.rheumatology.org/practice/clinical/patients/medications/mycophenolate.asp through http://www.rheumatology.org. Last updated May 2012. Accessed December 10, 2014.

Mycophenolate. MedlinePlus. Available online at http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601081.html through http://www.nlm.nih.gov. Last updated June 15, 2014. Accessed December 10, 2014.

Myfortic. Rx List. Available online at http://www.rxlist.com/myfortic-drug/patient-images-side-effects.htm through http://www.rxlist.com. Copyright 2014. Accessed December 10, 2014.

Mycophenolate Mofetil (Oral Route). Mayo Clinic. Available online at http://www.mayoclinic.org/drugs-supplements/mycophenolate-mofetil-oral-route/side-effects/drg-20073191 through http://www.mayoclinic.org. Last updated September 1, 2014. Accessed December 10, 2014.

Mycophenolic Acid Drug Level. University of Iowa Department of Pathology. Available online at https://www.healthcare.uiowa.edu/path_handbook/handbook/test1087.html through https://www.healthcare.uiowa.edu. Last updated September 18, 2012. Accessed December 29, 2014.

Mycophenolic Acid, Serum. Available online at http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/81563 through http://www.mayomedicallaboratories.com. Copyright 1995-2014. Accessed December 29, 2014.

Mycophenolic Acid and Metabolites. ARUP Laboratories. Available online at http://ltd.aruplab.com/Tests/Pub/2010359 through http://ltd.aruplab.com. Copyright 2014. Accessed December 29, 2014.

Henry's Clinical Diagnosis and Management by Laboratory Methods. 22nd ed. McPherson R, Pincus M, eds. Philadelphia, PA: Saunders Elsevier: 2011, Pp 354-355.

Sources Used in Previous Reviews

Wu, A. (2006). Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders Elsevier, St. Louis, Missouri. Pp 1416-1419.

Bhorade, S. (2006 December, Revised). Medicines for Keeping Your New Heart or Lung Healthy. AST [On-line information]. PDF available for download at http://www.a-s-t.org/files/pdf/patient_education/english/AST-EdBroHEARTMED-ENG.pdf through http://www.a-s-t.org. Accessed on 11/10/07.

Aradhye, S. (2006 December, Revised). Medicines for Keeping Your New Kidney Healthy. AST [On-line information]. PDF available for download at http://www.a-s-t.org/files/pdf/patient_education/english/AST-EdBroKIDNEYMED-ENG.pdf through http://www.a-s-t.org. Accessed on 11/10/07.

(2007 August 1). Mycophenolate. MedlinePlus Drug Information [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a601081.html through http://www.nlm.nih.gov. Accessed on 11/7/07.

Cannon, M. (2006 June, Updated). Mycophenolate Mofetil. CR [On-line information]. Available online at http://www.rheumatology.org/public/factsheets/mycophenolate.asp through http://www.rheumatology.org. Accessed on 11/10/07.

Waknine, Y. (2006 June 9). New FDA Orphan Drugs: CellCept, ISIS 301012, 5-HMF. Medscape Medical News [On-line information]. Available online at http://www.medscape.com/viewarticle/535806 through http://www.medscape.com. Accessed on 11/10/07.

Pellegrino, B. and Schmidt, R. (2006 July 27). Immunosuppression. emedicine [On-line information]. Available online at http://www.medscape.com/viewarticle/565075 through http://www.medscape.com. Accessed on 11/10/07.

Waknine, Y. (2007 October 29). CellCept Linked to Pregnancy Loss, Congenital Malformations. Medscape Medical News [On-line information]. Available online at http://www.emedicine.com/med/TOPIC3558.HTM through http://www.emedicine.com. Accessed on11/10/07.

Horsien, S. et. al. (2007 May 17). Pediatric Transplantation in the United States, 1996-2005. Medscape from Am J Transplant 2007;7(5):1339-1358. [On-line information]. Available online at http://www.medscape.com/viewarticle/556002 through http://www.medscape.com. Accessed on11/10/07.

(© 2007). Mycophenolic Acid. ARUP's Laboratory Test Directory [On-line information]. Available online at http://www.aruplab.com/guides/ug/tests/0090213.jsp through http://www.aruplab.com. Accessed on 11/10/07.

(© 2007). Mycophenolic Acid and Metabolite. LabCorp [On-line information]. Available online at http://www.labcorp.com/datasets/labcorp/html/chapter/ through http://www.labcorp.com. Accessed on 11/10/07.

(© 1998-2001). CellCept®. Roche.

(2004 February). Myfortic®. CDER, [email protected] [On-line information]. PDF available for download at http://www.fda.gov/cder/foi/label/2003/50759slr008,50758slr005,50723slr006,50722slr008cellcept_lbl.pdf through http://www.nlm.nih.gov. Accessed on 11/7/07.

(December 12 2009). MedlinePlus Drug Information. Mycophenolate. Available online at http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a601081.html. Accessed August 2011.

(May 20, 2008) Transplant Living. Mycophenolic Acid. Available online through http://www.transplantliving.org. Accessed August 2011.

(©2010) American College of Rheumatology. Practice Management, Mycophenolate. Available online at http://www.rheumatology.org/practice/clinical/patients/medications/mycophenolate.asp through http://www.rheumatology.org. Accessed August 2011.

(July 14, 2009) U.S. Food and Drug Administration. Information for Healthcare Professionals: Immunosuppressant Drugs: Required Labeling Changes. Available online through http://www.fda.gov/. Accessed July 2011.

Food and Drug Administration. Prescribing Information (Approval 1999). PDF available for download at http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021083s033,021110s043lbl.pdf through http://www.accessdata.fda.gov. Accessed July 2011.

(©2011) Cleveland Clinic. Transplant programs: Mycophenolate Mofetil. Available online at http://my.clevelandclinic.org/transplant/services/kidney/mycophenolate.aspx through http://my.clevelandclinic.org. Accessed August 2011 .

(©2011) eMedicine Health. Drugs and Medications, Mycophenolate Mofetil. Available online at http://www.emedicinehealth.com/drug-mycophenolate_mofetil/article_em.htm through http://www.emedicinehealth.com. Accessed August 2011 .

Clarke, W. and Dufour, D. R., Editors (2006). Contemporary Practice in Clinical Chemistry, AACC Press, Washington, DC. Pg 463.

Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed., Burtis CA and Ashwood ER, eds. Philadelphia: W. B. Saunders Company; 2005. Pp 1277-1278.

Jeong H, Kaplan B. Therapeutic Monitoring of Mycophenolate Mofetil. CJASN January 2007 vol. 2 no. 1 184-191. Available online at http://cjasn.asnjournals.org/content/2/1/184.full through http://cjasn.asnjournals.org. Accessed August 2011.

Ask a Laboratory Scientist

This form enables you to ask specific questions about lab tests. Your questions will be answered by a laboratory scientist as part of a voluntary service provided by one of our partners, American Society for Clinical Laboratory Science.

Disclaimer
Thank you for using the Consumer Information Response Service ("the Service") to inquire about the meaning of your lab test results.  The Service is provided free of charge by the American Society for Clinical Laboratory Science, which is one of many laboratory organizations that supports Lab Tests Online.
Please note that information provided through this free Service is not intended to be medical advice and should not be relied on as such. Although the laboratory provides the largest single source of objective, scientific data on patient status, it is only one part of a complex biological picture of health or disease. As professional clinical laboratory scientists, our goal is to assist you in understanding the purpose of laboratory tests and the general meaning of your laboratory results. It is important that you communicate with your physician so that together you can integrate the pertinent information, such as age, ethnicity, health history, signs and symptoms, laboratory and other procedures (radiology, endoscopy, etc.), to determine your health status. The information provided through this Service is not intended to substitute for such consultations with your physician nor specific medical advice to your health condition.
By submitting your question to this Service, you agree to waive, release, and hold harmless the American Society for Clinical Laboratory Science and its affiliates or their past or present officers, directors, employees, agents, and Service volunteers (collectively referred to as "ASCLS") and the American Association  for Clinical Chemistry and its affiliates or their past or present officers, directors, employees, agents, and Service volunteers (collectively referred to as "AACC") from any legal claims, rights, or causes of action you may have in connection with the responses provided to the questions that you submit to the Service.
AACC, ASCLS and its Service volunteers disclaim any liability arising out of your use of this Service or for any adverse outcome from your use of the information provided by this Service for any reason, including but not limited to any misunderstanding or misinterpretation of the information provided through this Service.